We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCC
1826
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$502K ﹤0.01%
21,269
+8,562
+67% +$156K
PGHY icon
1827
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$226M
$500K ﹤0.01%
22,656
-504
-2% -$11.2K
SPNT icon
1828
SiriusPoint
SPNT
$2.74B
$500K ﹤0.01%
49,622
+19,954
+67% +$209K
KURA icon
1829
Kura Oncology
KURA
$817M
$499K ﹤0.01%
23,952
+1,096
+5% +$27.2K
FIRY
1830
Firy Inc
FIRY
$154M
$499K ﹤0.01%
+1,150
New +$411K
SSNC icon
1831
SS&C Technologies
SSNC
$18.6B
$499K ﹤0.01%
6,918
-26,373
-79% -$1.93M
CORT icon
1832
Corcept Therapeutics
CORT
$12B
$498K ﹤0.01%
22,649
-1,521
-6% -$33.8K
VNT icon
1833
Vontier
VNT
$4.73B
$498K ﹤0.01%
+15,308
New +$504K
VIVO
1834
DELISTED
Meridian Bioscience Inc
VIVO
$498K ﹤0.01%
22,461
-1,618
-7% -$34.3K
IBP icon
1835
Installed Building Products
IBP
$6.51B
$496K ﹤0.01%
4,055
-386
-9% -$47.1K
LSTR icon
1836
Landstar System
LSTR
$6.09B
$496K ﹤0.01%
3,137
-2,254
-42% -$379K
NKLA
1837
DELISTED
Nikola Corporation Common Stock
NKLA
$496K ﹤0.01%
916
-954
-51% -$397K
BSMX
1838
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$495K ﹤0.01%
78,866
-42,738
-35% -$251K
PBA icon
1839
Pembina Pipeline
PBA
$27.4B
$494K ﹤0.01%
15,520
-14,703
-49% -$461K
CPA icon
1840
Copa Holdings
CPA
$6.15B
$489K ﹤0.01%
6,493
-4,440
-41% -$358K
FIX icon
1841
Comfort Systems
FIX
$61.1B
$488K ﹤0.01%
6,194
-528
-8% -$43K
FCNCA icon
1842
First Citizens BancShares
FCNCA
$25.4B
$486K ﹤0.01%
584
+244
+72% +$208K
STLA icon
1843
Stellantis
STLA
$21.2B
$484K ﹤0.01%
24,541
-31,786
-56% -$597K
TILE icon
1844
Interface
TILE
$2.01B
$484K ﹤0.01%
31,656
+12,732
+67% +$183K
HQL
1845
abrdn Life Sciences Investors
HQL
$605M
$483K ﹤0.01%
22,507
-1,760
-7% -$35.5K
VNDA icon
1846
Vanda Pharmaceuticals
VNDA
$306M
$479K ﹤0.01%
+22,287
New +$399K
CS
1847
DELISTED
Credit Suisse Group
CS
$478K ﹤0.01%
45,553
+23,700
+108% +$252K
TDF
1848
Templeton Dragon Fund
TDF
$274M
$477K ﹤0.01%
20,107
-649
-3% -$15K
PFS icon
1849
Provident Financial Services
PFS
$3.27B
$474K ﹤0.01%
20,710
+8,322
+67% +$201K
UFPI icon
1850
UFP Industries
UFPI
$5.24B
$472K ﹤0.01%
6,346
-2,280
-26% -$180K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.